$ALNY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALNYLAM PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALNYLAM PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Buy | M | 77.40 | 10,000 | 774,000 | 24,500 | 14.5 K to 24.5 K (+68.97 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 140.00 | 10,000 | 1,400,000 | 14,500 | 24.5 K to 14.5 K (-40.82 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Buy | M | 77.40 | 10,000 | 774,000 | 24,500 | 14.5 K to 24.5 K (+68.97 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | M | 63.86 | 2,117 | 135,192 | 0 | |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | M | 59.25 | 15,000 | 888,750 | 0 | |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Sell | S | 150.00 | 17,117 | 2,567,550 | 0 | 17.1 K to 0 (-100.00 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Buy | M | 59.25 | 15,000 | 888,750 | 17,117 | 2.1 K to 17.1 K (+708.55 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Buy | M | 63.86 | 2,117 | 135,192 | 2,117 | 0 to 2.1 K |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 21.35 | 15,000 | 320,250 | 0 | |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 149.00 | 15,000 | 2,235,000 | 140,795 | 155.8 K to 140.8 K (-9.63 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 21.35 | 15,000 | 320,250 | 155,795 | 140.8 K to 155.8 K (+10.65 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 30.09 | 10,000 | 300,900 | 0 | |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 63.86 | 2,823 | 180,277 | 0 | |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 59.25 | 15,000 | 888,750 | 0 | |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Sell | S | 150.00 | 27,823 | 4,173,450 | 0 | 27.8 K to 0 (-100.00 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 59.25 | 15,000 | 888,750 | 27,823 | 12.8 K to 27.8 K (+116.98 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 63.86 | 2,823 | 180,277 | 12,823 | 10 K to 12.8 K (+28.23 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 30.09 | 10,000 | 300,900 | 10,000 | 0 to 10 K |
Mar 13 2018 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 27.28 | 15,000 | 409,200 | 0 | |
Mar 13 2018 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 129.00 | 15,000 | 1,935,000 | 140,795 | 155.8 K to 140.8 K (-9.63 %) |
Mar 13 2018 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 27.28 | 15,000 | 409,200 | 155,795 | 140.8 K to 155.8 K (+10.65 %) |
Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 119.13 | 25,000 | 2,978,250 | 25,000 | |
Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | Soni Manmeet Singh | Chief Financial Off ... | Option Exercise | A | 119.13 | 8,938 | 1,064,784 | 8,938 | |
Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 119.13 | 4,000 | 476,520 | 4,000 | |
Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 119.13 | 52,500 | 6,254,325 | 52,500 | |
Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 119.13 | 13,750 | 1,638,038 | 13,750 | |
Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Option Exercise | A | 119.13 | 25,000 | 2,978,250 | 25,000 | |
Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 119.13 | 30,000 | 3,573,900 | 30,000 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 97.72 | 10,000 | 977,200 | 0 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 96.45 | 6,187 | 596,736 | 2,063 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 88.95 | 3,600 | 320,220 | 3,600 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 63.00 | 3,439 | 216,657 | 0 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 42.22 | 1,388 | 58,601 | 4,162 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 96.45 | 2,750 | 265,238 | 0 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 96.45 | 2,750 | 265,238 | 2,750 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 63.00 | 1,667 | 105,021 | 0 | |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 135.00 | 600 | 81,000 | 0 | 600 to 0 (-100.00 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 133.83 | 400 | 53,532 | 600 | 1,000 to 600 (-40.00 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 132.98 | 1,591 | 211,571 | 1,000 | 2.6 K to 1,000 (-61.40 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 132.18 | 12,405 | 1,639,693 | 2,591 | 15 K to 2.6 K (-82.72 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 131.20 | 16,500 | 2,164,800 | 14,996 | 31.5 K to 15 K (-52.39 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 130.42 | 5,249 | 684,575 | 31,496 | 36.7 K to 31.5 K (-14.28 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 63.00 | 3,439 | 216,657 | 36,745 | 33.3 K to 36.7 K (+10.33 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 96.45 | 6,187 | 596,736 | 33,306 | 27.1 K to 33.3 K (+22.81 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 97.72 | 10,000 | 977,200 | 27,119 | 17.1 K to 27.1 K (+58.41 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 96.45 | 2,750 | 265,238 | 17,119 | 14.4 K to 17.1 K (+19.14 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 96.45 | 2,750 | 265,238 | 14,369 | 11.6 K to 14.4 K (+23.67 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 88.95 | 3,600 | 320,220 | 11,619 | 8 K to 11.6 K (+44.89 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 63.00 | 1,667 | 105,021 | 8,019 | 6.4 K to 8 K (+26.24 %) |
Jan 08 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 42.22 | 1,388 | 58,601 | 6,352 | 5 K to 6.4 K (+27.96 %) |
Jan 03 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 0.00 | 8,502 | 0 | 0 | |
Jan 03 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Payment of Exercise | F | 127.05 | 3,538 | 449,503 | 4,964 | 8.5 K to 5 K (-41.61 %) |
Jan 03 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 0.00 | 8,502 | 0 | 8,502 | 0 to 8.5 K |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 42.22 | 1,388 | 58,601 | 1,388 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 6,250 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | M | 42.22 | 6,249 | 263,833 | 18,751 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 42.22 | 6,250 | 263,875 | 6,250 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 122.53 | 300 | 36,760 | 11,500 | 11.8 K to 11.5 K (-2.54 %) |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 121.68 | 1,900 | 231,182 | 11,800 | 13.7 K to 11.8 K (-13.87 %) |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 120.88 | 4,049 | 489,456 | 13,700 | 17.7 K to 13.7 K (-22.81 %) |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Buy | M | 42.22 | 6,249 | 263,833 | 17,749 | 11.5 K to 17.7 K (+54.34 %) |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 42.22 | 6,250 | 263,875 | 6,250 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Gift | G | 0.00 | 320 | 0 | 11,215 | 11.5 K to 11.2 K (-2.77 %) |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 42.22 | 6,250 | 263,875 | 6,250 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 63.00 | 1,587 | 99,981 | 148,413 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 6,250 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 63.00 | 1,587 | 99,981 | 151,297 | 149.7 K to 151.3 K (+1.06 %) |
Dec 05 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Option Exercise | M | 77.40 | 30,000 | 2,322,000 | 95,000 | |
Dec 05 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Sell | S | 137.29 | 6,199 | 851,061 | 11,500 | 17.7 K to 11.5 K (-35.02 %) |
Dec 05 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Sell | S | 136.50 | 9,700 | 1,324,050 | 17,699 | 27.4 K to 17.7 K (-35.40 %) |
Dec 05 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Sell | S | 135.56 | 7,500 | 1,016,700 | 27,399 | 34.9 K to 27.4 K (-21.49 %) |
Dec 05 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Sell | S | 134.59 | 3,801 | 511,577 | 34,899 | 38.7 K to 34.9 K (-9.82 %) |
Dec 05 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Sell | S | 133.37 | 2,800 | 373,436 | 38,700 | 41.5 K to 38.7 K (-6.75 %) |
Dec 05 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Buy | M | 77.40 | 30,000 | 2,322,000 | 41,500 | 11.5 K to 41.5 K (+260.87 %) |
Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 31.39 | 73,415 | 2,304,497 | 0 | |
Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 132.73 | 2,683 | 356,115 | 149,710 | 152.4 K to 149.7 K (-1.76 %) |
Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.82 | 20,433 | 2,693,478 | 152,393 | 172.8 K to 152.4 K (-11.82 %) |
Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 130.88 | 25,036 | 3,276,712 | 172,826 | 197.9 K to 172.8 K (-12.65 %) |
Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.97 | 25,263 | 3,283,432 | 197,862 | 223.1 K to 197.9 K (-11.32 %) |
Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 31.39 | 73,415 | 2,304,497 | 223,125 | 149.7 K to 223.1 K (+49.04 %) |
Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 31.39 | 74,000 | 2,322,860 | 73,415 | |
Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 130.22 | 600 | 78,131 | 149,710 | 150.3 K to 149.7 K (-0.40 %) |
Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.57 | 4,850 | 628,415 | 150,310 | 155.2 K to 150.3 K (-3.13 %) |
Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 128.48 | 10,571 | 1,358,204 | 155,160 | 165.7 K to 155.2 K (-6.38 %) |
Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 127.54 | 7,120 | 908,085 | 165,731 | 172.9 K to 165.7 K (-4.12 %) |
Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 126.60 | 28,399 | 3,595,399 | 172,851 | 201.3 K to 172.9 K (-14.11 %) |
Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 125.54 | 22,460 | 2,819,718 | 201,250 | 223.7 K to 201.3 K (-10.04 %) |
Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 31.39 | 74,000 | 2,322,860 | 223,710 | 149.7 K to 223.7 K (+49.43 %) |
Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 7,500 | |
Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 88.95 | 1,800 | 160,110 | 1,800 | |
Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 16,250 | |
Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 88.95 | 3,500 | 311,325 | 3,500 | |
Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 88.95 | 10,000 | 889,500 | 10,000 | |
Nov 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | M | 30.09 | 20,000 | 601,800 | 0 | |
Nov 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Sell | S | 130.00 | 20,000 | 2,600,000 | 0 | 20 K to 0 (-100.00 %) |
Nov 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Buy | M | 30.09 | 20,000 | 601,800 | 20,000 | 0 to 20 K |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 33,666 | 718,769 | 0 | |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 122.79 | 3,693 | 453,463 | 11,535 | 15.2 K to 11.5 K (-24.25 %) |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 121.69 | 17,755 | 2,160,606 | 15,228 | 33 K to 15.2 K (-53.83 %) |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 120.78 | 11,418 | 1,379,066 | 32,983 | 44.4 K to 33 K (-25.72 %) |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 119.79 | 800 | 95,832 | 44,401 | 45.2 K to 44.4 K (-1.77 %) |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 33,666 | 718,769 | 45,201 | 11.5 K to 45.2 K (+291.86 %) |
Oct 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 21.35 | 85,316 | 1,821,497 | 0 | |
Oct 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 125.00 | 85,316 | 10,664,500 | 100,428 | 185.7 K to 100.4 K (-45.93 %) |
Oct 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 21.35 | 85,316 | 1,821,497 | 185,744 | 100.4 K to 185.7 K (+84.95 %) |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 63.00 | 10,834 | 682,542 | 10,834 | |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 63.00 | 1,667 | 105,021 | 1,667 | |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 63.00 | 25,000 | 1,575,000 | 25,000 | |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 31.39 | 76,815 | 2,411,223 | 0 | |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 18.66 | 5,359 | 99,999 | 94,641 | |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 7.10 | 6,485 | 46,044 | 85,915 | |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 63.00 | 15,000 | 945,000 | 15,000 | |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 18.66 | 5,359 | 99,999 | 100,428 | 95.1 K to 100.4 K (+5.64 %) |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 7.10 | 6,485 | 46,044 | 95,069 | 88.6 K to 95.1 K (+7.32 %) |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 100.00 | 76,815 | 7,681,500 | 88,584 | 165.4 K to 88.6 K (-46.44 %) |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 31.39 | 76,815 | 2,411,223 | 165,399 | 88.6 K to 165.4 K (+86.71 %) |
Jul 11 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 96.45 | 11,709 | 1,129,333 | 23,418 | |
Jul 11 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 96.45 | 2,750 | 265,238 | 5,500 | |
Jul 11 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 96.45 | 25,000 | 2,411,250 | 50,000 | |
Jul 11 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 96.45 | 1,987 | 191,646 | 3,974 | |
Jul 11 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 96.45 | 15,875 | 1,531,144 | 31,750 | |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 328 | 7,003 | 33,666 | |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 18.66 | 1,340 | 25,004 | 44,641 | |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Payment of Exercise | F | 74.31 | 430 | 31,953 | 11,535 | 12 K to 11.5 K (-3.59 %) |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 18.66 | 1,340 | 25,004 | 11,965 | 10.6 K to 12 K (+12.61 %) |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 328 | 7,003 | 10,625 | 10.3 K to 10.6 K (+3.19 %) |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | SCHULMAN AMY W | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Sanofi | 10% Owner | Buy | P | 71.87 | 297,501 | 21,381,397 | 10,554,134 | 10.3 M to 10.6 M (+2.90 %) |
May 31 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Buy | P | 65.35 | 11,500 | 751,502 | 11,500 | 0 to 11.5 K |
May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 11,000 | 234,850 | 33,994 | |
May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 75.00 | 11,000 | 825,000 | 10,297 | 21.3 K to 10.3 K (-51.65 %) |
May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 11,000 | 234,850 | 21,297 | 10.3 K to 21.3 K (+106.83 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 18.66 | 5,625 | 104,963 | 0 | |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 7.10 | 3,750 | 26,625 | 0 | |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 70.00 | 9,375 | 656,250 | 0 | 9.4 K to 0 (-100.00 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 7.10 | 3,750 | 26,625 | 9,375 | 5.6 K to 9.4 K (+66.67 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 18.66 | 5,625 | 104,963 | 5,625 | 0 to 5.6 K |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Option Exercise | M | 31.39 | 32,750 | 1,028,023 | 0 | |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Option Exercise | M | 21.35 | 11,000 | 234,850 | 44,994 | |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Sell | S | 65.00 | 11,000 | 715,000 | 10,297 | 21.3 K to 10.3 K (-51.65 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Buy | M | 21.35 | 11,000 | 234,850 | 21,297 | 10.3 K to 21.3 K (+106.83 %) |